文献速递瓣膜外科

人工腱索二尖瓣修复失败预测因素

Predictors of Failure of Mitral Valve Repair Using Artificial Chordae.
PubMed 文献 · Ann Thorac Surg · 2021-05-19

两组再手术率相似,人工腱索组再手术主要原因为ePTFE断裂,CV-5断裂率高于CV-4。再手术危险因素包括术后心律失常、急诊手术、未置入瓣环、ePTFE断裂及缝线断裂。

要点

  • 人工腱索与缝线修复二尖瓣的长期再手术率相似。
  • ePTFE断裂是人工腱索组再手术的主要原因,CV-5断裂率高于CV-4。
  • 术后心律失常、急诊手术、未置入瓣环是再手术危险因素。

核心结论

  • 两种技术行二尖瓣修复的长期手术结局均可行。
  • 长期随访中CV-5的ePTFE断裂率高于CV-4。

主要发现

  • 人工腱索组再手术8例(2.6%),缝线修复组6例(5%)。
  • 人工腱索组再手术主要原因为ePTFE断裂(CV-4 1例,CV-5 6例),缝线修复组为缝线断裂。
  • ePTFE断裂再手术中位时间88个月,缝线修复组26个月。
  • ePTFE断裂率CV-5为1.8%,CV-4为0.2%。
  • 再手术危险因素包括术后心律失常、急诊手术、未置入瓣环、ePTFE断裂及缝线断裂。

关键数值与推荐

  • 人工腱索组5、10、15年免再手术率分别为99%、95%、93%,二尖瓣生存率分别为96%、91%、89%。
  • 缝线修复组5、10、15年免再手术率分别为96%、91%、91%,二尖瓣生存率分别为95%、94%、94%。

临床怎么用

  • 选用人工腱索时需关注ePTFE型号对长期断裂风险的影响。
  • 术后心律失常、急诊手术及未置入瓣环者应加强随访监测再手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated predictors of failure of mitral valve repair (MVr) using expanded polytetrafluoroethylene (ePTFE) and its durability in the long term in a single institution. METHODS: Four hundred twenty-one consecutive patients with primary mitral valve disease underwent MVr using artificial chordae (group A, n = 304) and suture repair (group S, n = 117) at our institution from January 2002 to April 2020. A comparison study was performed to examine the long-term outcomes, reoperation rate, and risk factors for reoperation. RESULTS: One hospital death and 5 late deaths occurred in group S, and 20 late deaths occurred in group A. The reoperation rates were similar: group A, n = 8 (2.6%); and group S, n = 6 (5%). The major cause of reoperation was ruptured ePTFE (CV-4, n = 1; CV-5, n = 6) in group A, and suture rupture in group S. Reoperation was performed after a median of 88 months for ruptured ePTFE, and 26 months for group S. The rate of ePTFE rupture was 1.8% with CV-5 and 0.2% with CV-4. Risk factors for reoperation included postoperative arrhythmia, urgent operation, no annular ring, ruptured ePTFE, and suture rupture. The rates of freedom from reoperation and actuarial mitral valve survival rates at 5, 10, and 15 years were 99%, 95%, and 93% and 96%, 91%, and 89%, respectively, in group A; and 96%, 91%, and 91% and 95%, 94%, and 94%, respectively, in group S. CONCLUSIONS: The long-term surgical outcomes of MVr using both techniques were feasible. Over the long term, the ePTFE rupture rate of CV-5 was higher than that of CV-4.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mutsuga M, Narita Y, Tokuda Y, et al. Predictors of Failure of Mitral Valve Repair Using Artificial Chordae. Ann Thorac Surg. 2021. PMID: 34022210. doi:10.1016/j.athoracsur.2021.04.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。